• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corticosteroids for COVID-19: the search for an optimum duration of therapy.

作者信息

Mishra Gyanshankar P, Mulani Jasmin

机构信息

Department of Respiratory Medicine, Indira Gandhi Government Medical College, Nagpur, Maharashtra 440018, India.

Department of Biochemistry, Government Medical College, Nagpur, Maharashtra, India.

出版信息

Lancet Respir Med. 2021 Jan;9(1):e8. doi: 10.1016/S2213-2600(20)30530-0. Epub 2020 Nov 26.

DOI:10.1016/S2213-2600(20)30530-0
PMID:33248469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7836750/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efc7/7836750/ce52441b6da3/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efc7/7836750/ce52441b6da3/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efc7/7836750/ce52441b6da3/fx1_lrg.jpg

相似文献

1
Corticosteroids for COVID-19: the search for an optimum duration of therapy.用于治疗新型冠状病毒肺炎的皮质类固醇：寻找最佳治疗时长
Lancet Respir Med. 2021 Jan;9(1):e8. doi: 10.1016/S2213-2600(20)30530-0. Epub 2020 Nov 26.
2
Therapeutic Application of Corticosteroids in COVID-19: A Focus on Optimum Dose and Duration of Therapy.皮质类固醇在COVID-19中的治疗应用：聚焦最佳治疗剂量和疗程
J Clin Pharmacol. 2021 Sep;61(9):1145-1148. doi: 10.1002/jcph.1929. Epub 2021 Jul 10.
3
[Corticosteroids treatment for COVID-19].[用于治疗2019冠状病毒病的皮质类固醇]
Rev Med Chil. 2020 Jul;148(7):893-894. doi: 10.4067/S0034-98872020000700893.
4
Corticosteroid use in viral pneumonia: experience so far and the dexamethasone breakthrough in coronavirus disease-2019.皮质类固醇在病毒性肺炎中的应用：迄今为止的经验和新冠肺炎中的地塞米松突破。
J Comp Eff Res. 2020 Dec;9(18):1247-1254. doi: 10.2217/cer-2020-0146. Epub 2020 Nov 27.
5
CJEM journal club: corticosteroids use for critically ill COVID-19 patients.《加拿大急诊医学杂志》期刊俱乐部：皮质类固醇用于危重症COVID-19患者
CJEM. 2021 Mar;23(2):162-163. doi: 10.1007/s43678-020-00056-w. Epub 2021 Jan 11.
6
Pros and cons of corticosteroid therapy for COVID-19 patients.COVID-19 患者使用皮质类固醇治疗的利弊。
Respir Physiol Neurobiol. 2020 Sep;280:103492. doi: 10.1016/j.resp.2020.103492. Epub 2020 Jul 10.
7
The Uncertain Role of Corticosteroids in the Treatment of COVID-19-Reply.皮质类固醇在新型冠状病毒肺炎治疗中的不确定作用——回复
JAMA Intern Med. 2021 Jan 1;181(1):140-141. doi: 10.1001/jamainternmed.2020.2435.
8
The Uncertain Role of Corticosteroids in the Treatment of COVID-19.皮质类固醇在治疗新型冠状病毒肺炎中的不确定作用
JAMA Intern Med. 2021 Jan 1;181(1):140. doi: 10.1001/jamainternmed.2020.2444.
9
Role of corticosteroids in the treatment of COVID-19 infection.皮质类固醇在新型冠状病毒肺炎感染治疗中的作用。
Minerva Anestesiol. 2020 Nov;86(11):1249-1250. doi: 10.23736/S0375-9393.20.14864-8. Epub 2020 Jun 12.
10
Corticosteroids in the Management of Pregnant Patients With Coronavirus Disease (COVID-19).皮质类固醇在冠状病毒病（COVID-19）孕妇管理中的应用
Obstet Gynecol. 2021 Feb 1;137(2):379-380. doi: 10.1097/AOG.0000000000004271.

引用本文的文献

1
Prolonged corticosteroid therapy and lung abnormalities in patients after severe COVID-19 pneumonia.重症 COVID-19 肺炎患者的长期皮质类固醇治疗与肺部异常
Sarcoidosis Vasc Diffuse Lung Dis. 2024 Dec 10;41(4):e2024052. doi: 10.36141/svdld.v41i4.14331.
2
High-Dose or Low-Dose Corticosteroids - Which Regimen is More Effective in Patients with Moderate to Severe COVID-19? A Retrospective Study.高剂量或低剂量皮质类固醇——哪种方案对中重度新冠肺炎患者更有效？一项回顾性研究。
Maedica (Bucur). 2024 Jun;19(2):330-334. doi: 10.26574/maedica.2024.19.2.330.
3
Severe COVID-19 infection: An institutional review and literature overview.

本文引用的文献

1
Impact of Corticosteroids in Coronavirus Disease 2019 Outcomes: Systematic Review and Meta-analysis.皮质类固醇对 2019 冠状病毒病结局的影响：系统评价和荟萃分析。
Chest. 2021 Mar;159(3):1019-1040. doi: 10.1016/j.chest.2020.10.054. Epub 2020 Oct 28.
2
Dexamethasone in hospitalised patients with COVID-19: addressing uncertainties.地塞米松用于住院的COVID-19患者：解决不确定性问题。
Lancet Respir Med. 2020 Dec;8(12):1170-1172. doi: 10.1016/S2213-2600(20)30503-8. Epub 2020 Oct 29.
3
Autopsy findings in COVID-19-related deaths: a literature review.
严重 COVID-19 感染：机构审查和文献综述。
PLoS One. 2024 Aug 20;19(8):e0304960. doi: 10.1371/journal.pone.0304960. eCollection 2024.
4
Therapeutic development targeting host heparan sulfate proteoglycan in SARS-CoV-2 infection.针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染中宿主硫酸乙酰肝素蛋白聚糖的治疗性开发。
Front Med (Lausanne). 2024 Mar 27;11:1364657. doi: 10.3389/fmed.2024.1364657. eCollection 2024.
5
Epidemiology, Clinical Profile, and Analysis of Risk Factors in COVID Associated Rhino-orbito-cerebral Mucormycosis Patients - An Observational Study.新冠相关鼻眶脑型毛霉菌病患者的流行病学、临床特征及危险因素分析——一项观察性研究
Indian J Endocrinol Metab. 2023 Nov-Dec;27(6):519-523. doi: 10.4103/ijem.ijem_372_22. Epub 2024 Jan 11.
6
The Efficacy of High-Dose Pulse Therapy vs. Low-Dose Intravenous Methylprednisolone on Severe to Critical COVID-19 Clinical Outcomes: A Randomized Clinical Trial.高剂量脉冲疗法与低剂量静脉注射甲泼尼龙对重症至危重症新型冠状病毒肺炎临床结局的疗效：一项随机临床试验
Iran J Pharm Res. 2023 Aug 26;22(1):e137838. doi: 10.5812/ijpr-137838. eCollection 2023 Jan-Dec.
7
Identification of new drugs to counteract anti-spike IgG-induced hyperinflammation in severe COVID-19.鉴定对抗严重 COVID-19 中抗刺突 IgG 诱导的过度炎症的新型药物。
Life Sci Alliance. 2023 Sep 12;6(11). doi: 10.26508/lsa.202302106. Print 2023 Nov.
8
COVID-19: An Overview of SARS-CoV-2 Variants-The Current Vaccines and Drug Development.新型冠状病毒肺炎（COVID-19）：严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）变异株概述——当前疫苗和药物研发进展。
Biomed Res Int. 2023 Aug 29;2023:1879554. doi: 10.1155/2023/1879554. eCollection 2023.
9
Potential Impact of Long COVID-19 on Orthodontic Treatment.新冠长期症状对正畸治疗的潜在影响。
Eur J Dent. 2024 Feb;18(1):387-391. doi: 10.1055/s-0043-1768467. Epub 2023 Jun 19.
10
Artificial-Intelligence-Driven Algorithms for Predicting Response to Corticosteroid Treatment in Patients with Post-Acute COVID-19.用于预测急性 COVID-19 后患者对皮质类固醇治疗反应的人工智能驱动算法
Diagnostics (Basel). 2023 May 16;13(10):1755. doi: 10.3390/diagnostics13101755.
COVID-19 相关死亡的尸检结果：文献综述。
Forensic Sci Med Pathol. 2021 Jun;17(2):279-296. doi: 10.1007/s12024-020-00310-8. Epub 2020 Oct 7.
4
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
5
Rationale for Prolonged Corticosteroid Treatment in the Acute Respiratory Distress Syndrome Caused by Coronavirus Disease 2019.2019冠状病毒病所致急性呼吸窘迫综合征长期使用皮质类固醇治疗的理论依据
Crit Care Explor. 2020 Apr 29;2(4):e0111. doi: 10.1097/CCE.0000000000000111. eCollection 2020 Apr.
6
Psychiatric adverse effects of corticosteroids.皮质类固醇的精神科不良反应。
Mayo Clin Proc. 2006 Oct;81(10):1361-7. doi: 10.4065/81.10.1361.
7
Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome.皮质类固醇对持续性急性呼吸窘迫综合征的疗效与安全性
N Engl J Med. 2006 Apr 20;354(16):1671-84. doi: 10.1056/NEJMoa051693.
8
Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers.短期糖皮质激素对健康志愿者止血因子的影响。
Thromb Res. 2006;118(2):247-52. doi: 10.1016/j.thromres.2005.06.006. Epub 2005 Jul 11.